Justin Hanes is the founder of Theraly, Inc., Theraly Diabetes, Inc., and GrayBug, LLC. Justin is also a founder and former director of Kala Pharmaceuticals. Currently, Justin serves as the Lewis J. Ort Professor at the Wilmer Eye Institute at Johns Hopkins University. Hanes holds a Ph.D. in Chemical Engineering from Massachusetts Institute of Technology and a BS in Chemical Engineering from UCLA.
May, 2011 - present